TY - JOUR
T1 - Making a picture worth a thousand numbers
T2 - recommendations for graphically displaying patient-reported outcomes data
AU - PRO Data Presentation Delphi Panel
AU - Snyder, Claire
AU - Smith, Katherine
AU - Holzner, Bernhard
AU - Rivera, Yonaira M.
AU - Bantug, Elissa
AU - Brundage, Michael
AU - Weber, Daniel
AU - Basch, Ethan
AU - Aaronson, Neil
AU - Reeve, Bryce
AU - Velikova, Galina
AU - Heckert, Andrea
AU - Stotsky-Himelfarb, Eden
AU - Chauhan, Cynthia
AU - Hoffman, Vanessa
AU - Ganz, Patricia
AU - Barbera, Lisa
AU - Frank, Elizabeth
AU - Smith, Mary Lou
AU - Durazo, Arturo
AU - Needham, Judy
AU - Nasso, Shelley Fuld
AU - Miller, Robert
AU - Smith, Tenbroeck
AU - Struth, Deborah
AU - Rein, Alison
AU - Dias, Andre
AU - Roberts, Charlotte
AU - Smider, Nancy
AU - Cook, Gena
AU - Bjorner, Jakob
AU - Witteman, Holly
AU - Dolan, James G.
AU - Blazeby, Jane
AU - Golub, Robert M.
AU - Laine, Christine
AU - Ramsey, Scott
N1 - Publisher Copyright:
© 2018, Springer Nature Switzerland AG.
PY - 2019/2/15
Y1 - 2019/2/15
N2 - Purpose: Patient-reported outcomes (PROs) can promote patient-centered care in multiple ways: (1) using an individual patient’s PRO data to inform his/her management, (2) providing PRO results from comparative research studies in patient educational materials/decision aids, and (3) reporting PRO results from comparative research studies in peer-reviewed publications. Patients and clinicians endorse the value of PRO data; however, variations in how PRO measures are scored and scaled, and in how the data are reported, make interpretation challenging and limit their use in clinical practice. We conducted a modified Delphi process to develop stakeholder-engaged, evidence-based recommendations for PRO data display for the three above applications to promote understanding and use. Methods: The Consensus Panel included cancer survivors/caregivers, oncologists, PRO researchers, and application-specific end-users (e.g., electronic health record vendors, decision aid developers, journal editors). We reviewed the data display issues and their evidence base during pre-meeting webinars. We then surveyed participants’ initial perspectives, which informed discussions during an in-person meeting to develop consensus statements. These statements were ratified via a post-meeting survey. Results: Issues addressed by consensus statements relevant to both individual and research data applications were directionality (whether higher scores are better/worse) and conveying score meaning (e.g., none/mild/moderate/severe). Issues specific to individual patient data presentation included representation (bar charts vs. line graphs) and highlighting possibly concerning scores (absolute and change). Issues specific to research study results presentation included handling normed data, conveying statistically significant differences, illustrating clinically important differences, and displaying proportions improved/stable/worsened. Conclusions: The recommendations aim to optimize accurate and meaningful interpretation of PRO data.
AB - Purpose: Patient-reported outcomes (PROs) can promote patient-centered care in multiple ways: (1) using an individual patient’s PRO data to inform his/her management, (2) providing PRO results from comparative research studies in patient educational materials/decision aids, and (3) reporting PRO results from comparative research studies in peer-reviewed publications. Patients and clinicians endorse the value of PRO data; however, variations in how PRO measures are scored and scaled, and in how the data are reported, make interpretation challenging and limit their use in clinical practice. We conducted a modified Delphi process to develop stakeholder-engaged, evidence-based recommendations for PRO data display for the three above applications to promote understanding and use. Methods: The Consensus Panel included cancer survivors/caregivers, oncologists, PRO researchers, and application-specific end-users (e.g., electronic health record vendors, decision aid developers, journal editors). We reviewed the data display issues and their evidence base during pre-meeting webinars. We then surveyed participants’ initial perspectives, which informed discussions during an in-person meeting to develop consensus statements. These statements were ratified via a post-meeting survey. Results: Issues addressed by consensus statements relevant to both individual and research data applications were directionality (whether higher scores are better/worse) and conveying score meaning (e.g., none/mild/moderate/severe). Issues specific to individual patient data presentation included representation (bar charts vs. line graphs) and highlighting possibly concerning scores (absolute and change). Issues specific to research study results presentation included handling normed data, conveying statistically significant differences, illustrating clinically important differences, and displaying proportions improved/stable/worsened. Conclusions: The recommendations aim to optimize accurate and meaningful interpretation of PRO data.
KW - Cancer
KW - Clinical practice
KW - Consensus statements
KW - Data display
KW - Patient-reported outcomes
UR - http://www.scopus.com/inward/record.url?scp=85055268644&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055268644&partnerID=8YFLogxK
U2 - 10.1007/s11136-018-2020-3
DO - 10.1007/s11136-018-2020-3
M3 - Article
C2 - 30306533
AN - SCOPUS:85055268644
SN - 0962-9343
VL - 28
SP - 345
EP - 356
JO - Quality of Life Research
JF - Quality of Life Research
IS - 2
ER -